Terms: = Liver cancer AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1 AND Staging
12 results:
1. Development and External Validation of a Nomogram Including Body Composition Parameters for Predicting Early Recurrence of Hepatocellular Carcinoma After Hepatectomy.
Shi S; Zhao YX; Fan JL; Chang LY; Yu DX
Acad Radiol; 2023 Dec; 30(12):2940-2953. PubMed ID: 37798207
[TBL] [Abstract] [Full Text] [Related]
2. A nomogram for predicting cause-specific mortality among patients with cecal carcinoma: a study based on SEER database.
Zhou Q; Zhan Y; Guo J
BMC Gastroenterol; 2023 May; 23(1):177. PubMed ID: 37221487
[TBL] [Abstract] [Full Text] [Related]
3. [Establishment of artificial neural network model for predicting lymph node metastasis in patients with stage Ⅱ-Ⅲ gastric cancer].
Xue Z; Lu J; Lin J; Huang CM; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Zheng CH
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Apr; 25(4):327-335. PubMed ID: 35461201
[No Abstract] [Full Text] [Related]
4. Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
Nadarevic T; Giljaca V; Colli A; Fraquelli M; Casazza G; Miletic D; Štimac D
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013362. PubMed ID: 34611889
[TBL] [Abstract] [Full Text] [Related]
5. Clinical features of patients with HER2-positive breast cancer and development of a nomogram for predicting survival.
Fan Y; Wang Y; He L; Imani S; Wen Q
ESMO Open; 2021 Aug; 6(4):100232. PubMed ID: 34392135
[TBL] [Abstract] [Full Text] [Related]
6. A model to estimate survival in ambulatory patients with hepatocellular carcinoma: Can it predict the natural course of hepatocellular carcinoma?
Choi WM; Yu SJ; Ahn H; Cho H; Cho YY; Lee M; Yoo JJ; Cho Y; Lee DH; Cho EJ; Lee JH; Kim YJ; Yoon JH
Dig Liver Dis; 2017 Nov; 49(11):1273-1279. PubMed ID: 28807489
[TBL] [Abstract] [Full Text] [Related]
7. Systematic review and meta-analysis of hepatic resection versus transarterial chemoembolization for solitary large hepatocellular carcinoma.
Stevens CL; Awad A; Abbas SM; Watters DAK
HPB (Oxford); 2017 Aug; 19(8):653-658. PubMed ID: 28427829
[TBL] [Abstract] [Full Text] [Related]
8. Living or Brain-dead Donor liver Transplantation for Hepatocellular Carcinoma: A Multicenter, Western, Intent-to-treat Cohort Study.
Azoulay D; Audureau E; Bhangui P; Belghiti J; Boillot O; Andreani P; Castaing D; Cherqui D; Irtan S; Calmus Y; Chazouillères O; Soubrane O; Luciani A; Feray C
Ann Surg; 2017 Dec; 266(6):1035-1044. PubMed ID: 27617853
[TBL] [Abstract] [Full Text] [Related]
9. Predicting the severity of liver cirrhosis through clinical parameters.
Zhang EL; Zhang ZY; Wang SP; Xiao ZY; Gu J; Xiong M; Chen XP; Huang ZY
J Surg Res; 2016 Aug; 204(2):274-281. PubMed ID: 27565061
[TBL] [Abstract] [Full Text] [Related]
10. The potential value of volume-based quantitative PET parameters and increased bone marrow uptake for the prediction of survival in patients with malignant pleural mesothelioma.
Ozmen O; Koyuncu A; Koksal D; Tatci E; Alagoz E; Demirag F; Gokcek A; Arslan N
Nucl Med Commun; 2016 Jan; 37(1):43-9. PubMed ID: 26440572
[TBL] [Abstract] [Full Text] [Related]
11. Selecting a short-term prognostic model for hepatocellular carcinoma: comparison between the model for end-stage liver disease (MELD), MELD-sodium, and five cancer staging systems.
Huo TI; Hsia CY; Huang YH; Lin HC; Lee PC; Lui WY; Chiang JH; Chiou YY; Loong CC; Lee SD
J Clin Gastroenterol; 2009 Sep; 43(8):773-81. PubMed ID: 19262404
[TBL] [Abstract] [Full Text] [Related]
12. A new prognostic system for hepatocellular carcinoma including recurrent cases: a study of 861 patients in a single institution.
Toyama T; Hiramatsu N; Yakushijin T; Oze T; Nakanishi F; Yasumaru M; Mochizuki K; Kanto T; Takehara T; Kasahara A; Hayashi N
J Clin Gastroenterol; 2008 Mar; 42(3):317-22. PubMed ID: 18223490
[TBL] [Abstract] [Full Text] [Related]